Apr 30

What Can Biologics Modelling Do For You?

Dr. Dan Cannon

Senior Scientist II at Schrödinger

Protein-based drugs are one of the most important classes of therapeutics. Despite this, the field of rational design of biologics remains challenging. Recently, in silico technologies have emerged as valuable tools in both discovery and development.

In this lunch seminar, we will discuss how a range of computational solutions can be used to overcome typical problems in the field including structure prediction, epitope mapping, protein engineering and developability.

These solutions integrate into Schrödinger’s design platform, and we will show how engaging with us via software, services or consultancy could build upon your expertise to attain your goals faster.

Back To Top